217 related articles for article (PubMed ID: 25228735)
21. Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays.
Tsutsumi A; Hayashi T; Chino Y; Mamura M; Goto D; Matsumoto I; Ito S; Sumida T
Mod Rheumatol; 2006; 16(3):158-64. PubMed ID: 16767554
[TBL] [Abstract][Full Text] [Related]
22. Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?
Bardin N; Alessi MC; Dignat-George F; Vague IJ; Sampol J; Harlé JR; Sanmarco M
Immunobiology; 2007; 212(7):557-65. PubMed ID: 17678713
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
Litvinova E; Darnige L; Kirilovsky A; Burnel Y; de Luna G; Dragon-Durey MA
Front Immunol; 2018; 9():2971. PubMed ID: 30619328
[No Abstract] [Full Text] [Related]
24. Antiprothrombin antibody: why do we need more assays?
Atsumi T; Koike T
Lupus; 2010 Apr; 19(4):436-9. PubMed ID: 20353984
[TBL] [Abstract][Full Text] [Related]
25. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
26. Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study.
Sciascia S; Radin M; Cecchi I; Rubini E; Scotta A; Rolla R; Montaruli B; Pergolini P; Mengozzi G; Muccini E; Baldovino S; Ferro M; Vaccarino A; Mahler M; Menegatti E; Roccatello D
Front Immunol; 2019; 10():376. PubMed ID: 30891041
[No Abstract] [Full Text] [Related]
27. Antibodies to phosphatidylserine/prothrombin (aPS/PT) enhanced the diagnostic performance in Chinese patients with antiphospholipid syndrome.
Zhang S; Wu Z; Zhang W; Zhao J; Norman GL; Zeng X; Zhang F; Li Y
Clin Chem Lab Med; 2018 May; 56(6):939-946. PubMed ID: 29561729
[TBL] [Abstract][Full Text] [Related]
28. Detection of antiphosphatidylserine/prothrombin antibodies and their potential diagnostic value.
Žigon P; Čučnik S; Ambrožič A; Kveder T; Šemrl SS; Rozman B; Božič B
Clin Dev Immunol; 2013; 2013():724592. PubMed ID: 24187565
[TBL] [Abstract][Full Text] [Related]
29. A Novel ELISA Assay for the Detection of Anti-Prothrombin Antibodies in Antiphospholipid Syndrome Patients at High Risk of Thrombosis.
Chinnaraj M; Pengo V; Pozzi N
Front Immunol; 2021; 12():741589. PubMed ID: 34567006
[TBL] [Abstract][Full Text] [Related]
30. Microangiopathic antiphospholipid antibody syndrome due to anti-phosphatidylserine/prothrombin complex IgM antibody.
Senda Y; Ohta K; Yokoyama T; Shimizu M; Furuichi K; Wada T; Yachie A
Pediatr Int; 2017 Mar; 59(3):378-380. PubMed ID: 28317300
[TBL] [Abstract][Full Text] [Related]
31. Laboratory Evaluation of Antiphospholipid Syndrome.
Heikal N; Martins TB; White SK; Willis R; Ware Branch D; Schmidt RL; Tebo AE
Am J Clin Pathol; 2019 Oct; 152(5):638-646. PubMed ID: 31305881
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
33. Autoantibodies to prothrombin and phosphatidylserine/prothrombin-complexes: do they contribute to the serodiagnosis of primary and secondary anti-phospholipid syndrome?
Jaekel HP; Trabandt A; Schmid D; Grobe N; Müller EW; Ziutelis V; Kaskel-Paul S; Höh H; Bauer B; Sudik R; Baldauf A; Werle E
Clin Lab; 2004; 50(5-6):295-304. PubMed ID: 15209438
[TBL] [Abstract][Full Text] [Related]
34. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome.
Kopytek M; Natorska J; Undas A
Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587
[TBL] [Abstract][Full Text] [Related]
35. Synergistic thrombotic risk of antibodies against phosphatidylserine and prothrombin and β-2-glycoprotein I.
Kim H; Kim JE; Hwang SM; Lee HR; Han KS; Kim HK
Clin Appl Thromb Hemost; 2014 May; 20(4):442-7. PubMed ID: 23892687
[TBL] [Abstract][Full Text] [Related]
36. Human monoclonal antibodies against the complex of phosphatidylserine and prothrombin from patients with the antiphospholipid antibodies.
Horita T; Ichikawa K; Kataoka H; Yasuda S; Atsumi T; Koike T
Lupus; 2007; 16(7):509-16. PubMed ID: 17670850
[TBL] [Abstract][Full Text] [Related]
37. [Pathogenesis and Laboratory Findings in Antiphospholipid Syndrome, Especially Associated with Lupus Anticoagulant].
Ieko M; Naito S; Yoshida M; Takahashi N
Rinsho Byori; 2015 Oct; 63(10):1220-7. PubMed ID: 26897860
[TBL] [Abstract][Full Text] [Related]
38. Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS?
Pregnolato F; Chighizola CB; Encabo S; Shums Z; Norman GL; Tripodi A; Chantarangkul V; Bertero T; De Micheli V; Borghi MO; Meroni PL
Immunol Res; 2013 Jul; 56(2-3):432-8. PubMed ID: 23572433
[TBL] [Abstract][Full Text] [Related]
39. IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.
Tonello M; Mattia E; Favaro M; Del Ross T; Calligaro A; Salvan E; Hoxha A; Fedrigo M; Ruffatti A
Thromb Res; 2019 May; 177():157-160. PubMed ID: 30903876
[TBL] [Abstract][Full Text] [Related]
40. Antiphosphatidylserine/prothrombin Antibodies in Antiphospholipid Syndrome with Intrauterine Growth Restriction and Preeclampsia.
Canti V; Del Rosso S; Tonello M; Lucianò R; Hoxha A; Coletto LA; Vaglio Tessitore I; Rosa S; Manfredi AA; Castiglioni MT; Ruffatti A; Rovere-Querini P
J Rheumatol; 2018 Aug; 45(9):1263-1272. PubMed ID: 30008452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
